 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/22/2024 |
$5.01 |
$5.27 |
$5.00 |
$5.17 |
265.40K | | 04/23/2024 |
$5.17 |
$5.34 |
$5.10 |
$5.13 |
293.90K | | 04/24/2024 |
$5.09 |
$5.14 |
$4.77 |
$4.83 |
365.90K | | 04/25/2024 |
$4.78 |
$5.06 |
$4.72 |
$4.88 |
231.20K | | 04/26/2024 |
$4.87 |
$5.11 |
$4.87 |
$5.02 |
167.40K |
|
|
| Puma Biotechnology is a biopharmaceutical company with a focus on the development and commercialization of products to enhance cancer care. Co. in-licenses from Pfizer, Inc., the global development and commercialization rights to PB272 (neratinib (oral)), PB272 (neratinib (intravenous)) and PB357. Neratinib is an irreversible tyrosine kinase inhibitor that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2 and HER4. Co. is primarily focused on the development and commercialization of the oral version of neratinib, and its drug candidates are directed at the treatment of HER2-positive breast cancer and HER2 mutated cancers. | |
|
Puma Biotechnology (PBYI) has the following price history information. Looking back at PBYI historical stock prices for the last five trading days, on April 22, 2024, PBYI opened at $5.01, traded as high as $5.27 and as low as $5.00, and closed at $5.17. Trading volume was a total of 265.40K shares. On April 23, 2024, PBYI opened at $5.17, traded as high as $5.34 and as low as $5.10, and closed at $5.13. Trading volume was a total of 293.90K shares. On April 24, 2024, PBYI opened at $5.09, traded as high as $5.14 and as low as $4.77, and closed at $4.83. Trading volume was a total of 365.90K shares. On April 25, 2024, PBYI opened at $4.78, traded as high as $5.06 and as low as $4.72, and closed at $4.88. Trading volume was a total of 231.20K shares. On April 26, 2024, PBYI opened at $4.87, traded as high as $5.11 and as low as $4.87, and closed at $5.02. Trading volume was a total of 167.40K shares.
PBYI Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Puma Biotechnology shares, starting with a $10,000 purchase of PBYI, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/29/2014 |
|
| End date: |
04/26/2024 |
|
| Start price/share: |
$74.73 |
|
| End price/share: |
$5.02 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-93.28% |
|
| Average Annual Total Return: |
-23.67% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$671.36 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/22/2024 | $5.17 | | 04/23/2024 | $5.13 | | 04/24/2024 | $4.83 | | 04/25/2024 | $4.88 | | 04/26/2024 | $5.02 |
|
|
Free PBYI Email Alerts:
